Data as of 3:22pm ET
| -0.0031 / -0.38%|
The 2 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +629.93% increase from the last price of 0.82.
The current consensus among 1 polled investment analysts is to Buy stock in Opexa Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.